Context Therapeutics Inc. (CNTX) Ownership
CNTX ownership summary
as of October 18, 2026- Institutions
- 68.7% of shares outstanding
- Insiders
- 1.57% of shares outstanding
- Shares outstanding
- 91.9M
- Float
- 63.7M shares available to trade
- Short interest
- 5.91% 4.7M shares short
- Days to cover
- 3.89 short interest down 31.8% vs prior month
- Institutions 68.73%
- Insiders 1.57%
- Other investors 29.70%
CNTX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Deep Track Capital, LP | 8.08% | 7.4M | $1.8M | — | June 30, 2026 |
| 2 | Nextech Invest, Ltd. | 8.08% | 7.4M | $1.8M | — | June 30, 2026 |
| 3 | Soleus Capital Management, L.P. | 7.69% | 7.1M | $1.7M | +100,000 (+1.4%) | June 30, 2026 |
| 4 | BlackRock Inc | 6.71% | 6.2M | $1.5M | +5.3M (+628.6%) | June 30, 2026 |
| 5 | Avidity Partners Management LP | 5.44% | 5.0M | $1.2M | −5.0M (−50.0%) | June 30, 2026 |
| 6 | Franklin Templeton Inc | 4.14% | 3.8M | $928,014 | — | June 30, 2026 |
| 7 | Vanguard Capital Management, LLC | 3.74% | 3.4M | $837,421 | +99 (+0.0%) | June 30, 2026 |
| 8 | Octagon Capital Advisors LP | 3.32% | 3.0M | $744,200 | −2.2M (−41.9%) | June 30, 2026 |
| 9 | Blue Owl Capital Holdings LP | 3.19% | 2.9M | $715,900 | −2.2M (−42.3%) | June 30, 2026 |
| 10 | TCG Crossover Management, LLC | 2.92% | 2.7M | $654,578 | — | June 30, 2026 |
| 11 | Geode Capital Management, LLC | 1.99% | 1.8M | $446,595 | +1.2M (+203.1%) | June 30, 2026 |
| 12 | State Street Corp | 1.54% | 1.4M | $344,876 | +1.2M (+505.3%) | June 30, 2026 |
| 13 | MPM Oncology Impact Management LP | 1.41% | 1.3M | $316,967 | −9.4M (−87.8%) | June 30, 2026 |
| 14 | Renaissance Technologies Corp | 1.13% | 1.0M | $254,101 | +858,400 (+469.1%) | June 30, 2026 |
| 15 | Acadian Asset Management LLC | 1.10% | 1.0M | $246,661 | +1.0M (0.0%) | June 30, 2026 |
| 16 | ADAR1 Capital Management LLC | 0.82% | 751K | $183,236 | +399,875 (+113.9%) | June 30, 2026 |
| 17 | Jane Street Group LLC | 0.70% | 645K | $157,431 | +208,278 (+47.7%) | June 30, 2026 |
| 18 | Vanguard Portfolio Management, LLC | 0.70% | 639K | $155,886 | +638,878 (0.0%) | June 30, 2026 |
| 19 | Northern Trust Corp | 0.67% | 616K | $150,201 | +512,320 (+496.2%) | June 30, 2026 |
| 20 | Vanguard Fiduciary Trust Co | 0.47% | 434K | $105,869 | +92,544 (+27.1%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 11.6M shares and 4 cut 18.7M.
CNTX top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.06% | 2.8M | $686,979 | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 2.55% | 2.3M | $571,280 | −27,008 (−1.1%) | September 30, 2026 |
| 3 | Fidelity Small Cap Index | 1.10% | 1.0M | $246,006 | −1,242 (−0.1%) | July 31, 2026 |
| 4 | iShares Russell 2000 Growth ETF | 0.96% | 883K | $215,381 | −1,117 (−0.1%) | September 30, 2026 |
| 5 | Vanguard Russell 2000 ETF | 0.58% | 534K | $130,212 | −6,824 (−1.3%) | September 30, 2026 |
| 6 | Abante Quant Value FI | 0.45% | 412K | $100,477 | +411,792 (0.0%) | August 31, 2026 |
| 7 | iShares Micro-Cap ETF | 0.33% | 299K | $72,885 | −2,060 (−0.7%) | September 30, 2026 |
| 8 | Calamos Market Neutral Income A | 0.30% | 278K | $67,785 | — | June 30, 2026 |
| 9 | Fidelity Extended Market Index | 0.30% | 277K | $67,483 | +27,137 (+10.9%) | August 31, 2026 |
| 10 | Belfund SICAV Belinvest Equity A USD Acc | 0.28% | 260K | $63,440 | — | August 31, 2026 |
| 11 | Schwab Small Cap Index | 0.25% | 228K | $55,595 | — | August 31, 2026 |
| 12 | iShares Russell 2000 Small-Cap Idx Instl | 0.22% | 203K | $49,624 | — | August 31, 2026 |
| 13 | Nuveen Quant Small Cap Equity R6 | 0.17% | 160K | $39,034 | — | August 31, 2026 |
| 14 | Nuveen Small Cap Blend Idx R6 | 0.14% | 126K | $30,626 | — | August 31, 2026 |
| 15 | EQ/2000 Managed Volatility IB | 0.11% | 104K | $25,312 | — | August 31, 2026 |
| 16 | Vanguard Russell 2000 Growth ETF | 0.11% | 101K | $24,648 | −4 (−0.0%) | September 30, 2026 |
| 17 | Fidelity Small Cap Growth Index | 0.11% | 100K | $24,302 | +11,202 (+12.7%) | July 31, 2026 |
| 18 | Fidelity Total Market Index | 0.11% | 98K | $23,818 | — | August 31, 2026 |
| 19 | Xtrackers Russell 2000 ETF 1C | 0.09% | 80K | $19,461 | −5,420 (−6.4%) | September 30, 2026 |
| 20 | Fidelity Series Total Market Index | 0.08% | 73K | $17,718 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CNTX insider transactions
latest 3| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-09 | Martin A Lehr | Buy | $0.70 | 100,000 | $70,000 |
| 2025-06-06 | Alex C Levit | Buy | $0.58 | 20,000 | $11,600 |
| 2025-06-06 | Jennifer Lynn Minai-Azary | Buy | $0.64 | 40,010 | $25,606 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CNTX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CNTX
Institutional investors own 68.7% of Context Therapeutics's shares and insiders 1.57%. The largest holder is Deep Track Capital, LP with 8.08% of the shares (7.4M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 4 reduced their stake in the latest filings. Short interest is 5.91% of the float, or 3.89 days of average trading volume. The share count rose 799.9% since 2020.
Related: CNTX analyst forecast, CNTX key metrics. See the CNTX stock overview for the latest quote and news.
CNTX ownership FAQ
Who owns the most Context Therapeutics stock?
The largest shareholders of Context Therapeutics are Deep Track Capital, LP (8.08%), Nextech Invest, Ltd. (8.08%), Soleus Capital Management, L.P. (7.69%), BlackRock Inc (6.71%), Avidity Partners Management LP (5.44%).
What percentage of Context Therapeutics is owned by institutions?
Institutions hold 68.7% of Context Therapeutics's shares outstanding; insiders hold 1.57%.
Which funds own Context Therapeutics?
The largest fund holders of Context Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (3.06%), iShares Russell 2000 ETF (2.55%), Fidelity Small Cap Index (1.10%), iShares Russell 2000 Growth ETF (0.96%), Vanguard Russell 2000 ETF (0.58%).
What is Context Therapeutics's short interest?
4.7M shares of Context Therapeutics were sold short, 5.91% of the float; at the average daily volume it would take 3.89 days to cover.
Are insiders buying or selling Context Therapeutics?
Of the latest 3 reported insider transactions in Context Therapeutics (since June 6, 2025), 3 were purchases and 0 were sales.
How many shares of Context Therapeutics are outstanding?
Context Therapeutics has 91.9M shares outstanding, of which 63.7M are in the public float.